Back
Amphastar Pharmaceuticals Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
53
AMPH
Amphastar Pharmaceuticals
Last Price:
41.12
Seasonality Move:
14.6%
Sell
28
APLS
Apellis Pharmaceuticals
Last Price:
49.84
Seasonality Move:
2.53%
Buy
53
Amphastar Pharmaceuticals (AMPH)
is a Buy
Is Amphastar Pharmaceuticals a Buy, Sell or Hold?
- The current Amphastar Pharmaceuticals [AMPH] share price is $40.83. The Score for AMPH is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- AMPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $47.93. The Score for APLS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals's stock price today?
-
The Amphastar Pharmaceuticals share price today is $40.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMPH is experiencing slight buying pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $47.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.25 | Sell |
| Relative Strength Index (14 RSI): | 42.54 | Sell |
| Chaikin Money Flow: | 68972 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.99 - 43.09) | Sell |
| Bollinger Bands (100): | (43.77 - 58.51) | Sell |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.92 | Sell |
| Relative Strength Index (14 RSI): | 34.15 | Sell |
| Chaikin Money Flow: | -224327 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.69 - 57.67) | Sell |
| Bollinger Bands (100): | (54.79 - 66.87) | Sell |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.31 | Buy |
| 20-day SMA: | 40.99 | Sell |
| 50-day SMA: | 45.04 | Sell |
| 200-day SMA: | 51.66 | Sell |
| 8-day EMA: | 40.56 | Buy |
| 20-day EMA: | 41.29 | Sell |
| 50-day EMA: | 44.55 | Sell |
| 200-day EMA: | 48.3 | Sell |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.64 | Sell |
| 20-day SMA: | 52.85 | Sell |
| 50-day SMA: | 58.37 | Sell |
| 200-day SMA: | 51.63 | Sell |
| 8-day EMA: | 49.3 | Sell |
| 20-day EMA: | 52.03 | Sell |
| 50-day EMA: | 56.09 | Sell |
| 200-day EMA: | 57.52 | Sell |
Amphastar Pharmaceuticals Earnings Growth & AMPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $0.06 per share, an increase this year of $0.31 per share, and an increase next year of $0.59 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.84 per share, an increase next quarter of $0.33 per share, an increase this year of $3.72 per share, and an increase next year of $2.02 per share.
Amphastar Pharmaceuticals Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||